CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-02 | PATEL DINESH V PH D President and CEO | Option exercise | +20,000 | $1.16 | $23K | 252,263 |
| 2018-04-02 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 58,203 | ||
| 2018-03-26 | PATEL DINESH V PH D President and CEO | Option exercise | +11,298 | $0.87 | $10K | 232,263 |
| 2018-03-26 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −11,298 | 0 | ||
| 2018-03-23 | CANAAN X L.P. 10% owner | Sale | −59,950 | $20.71 | $1.2M | 2,320,267 |
| 2018-03-22 | CANAAN X L.P. 10% owner | Sale | −4,759 | $20.62 | $98K | 2,380,217 |
| 2018-03-21 | CANAAN X L.P. 10% owner | Sale | −17,699 | $20.61 | $365K | 2,384,976 |
| 2018-03-20 | CANAAN X L.P. 10% owner | Sale | −17,060 | $20.61 | $352K | 2,402,675 |
| 2018-03-19 | CANAAN X L.P. 10% owner | Sale | −13,439 | $20.57 | $276K | 2,419,735 |
| 2018-03-16 | CANAAN X L.P. 10% owner | Sale | −6,926 | $20.51 | $142K | 2,433,174 |
| 2018-03-15 | CANAAN X L.P. 10% owner | Sale | −11,751 | $20.64 | $243K | 2,440,100 |
| 2018-03-14 | CANAAN X L.P. 10% owner | Sale | −200 | $20.77 | $4K | 2,451,851 |
| 2018-03-13 | CANAAN X L.P. 10% owner | Sale | −1,204 | $20.84 | $25K | 2,452,051 |
| 2018-03-12 | Liu David Y Chief Scientific Officer | Option exercise | +3,500 | $4.21 | $15K | 18,528 |
| 2018-03-12 | Liu David Y Chief Scientific Officer | Sale | −3,500 | $21.29 | $74K | 15,028 |
| 2018-03-12 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −3,500 | 35,331 | ||
| 2018-03-02 | Liu David Y Chief Scientific Officer | Option exercise | +875 | $1.89 | $2K | 14,197 |
| 2018-03-02 | Liu David Y Chief Scientific Officer | Sale | −875 | $20.00 | $18K | 13,322 |
| 2018-03-02 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −875 | 9,725 | ||
| 2018-02-28 | Shames Richard S. Chief Medical Officer | Grant or award | +6,500 | 6,500 |
Page 24 of 29 · 580 trades